Germany Biotechnology & Medical Research

Heidelberg Pharma AG (HPHA)

Track

Heidelberg Pharma AG recorded its most recent insider trading activity on March 9, 2026, involving two sell transactions by Dr. Birgit Kudlek. These disposals occurred outside the standard three-month window, following a series of historical purchase events by various individuals. No further market movements or current performance metrics are addressed regarding these past filings.
Ticker: HPHA Exchange: GER
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Heidelberg Pharma AG. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.1
Kudlek, Dr. Birgit Supervisory Board Member
Transaction date
Sale
Price
442.19
Quantity 98,761
Value €1,405,398
3.1
Kudlek, Dr. Birgit Supervisory Board Member
Transaction date
Sale
Price
458.77
Quantity 67,393
Value €593,776
1.3
Miller, Walter Management Board Member
Transaction date
Purchase
Price
405.04
Quantity 91,357
Value €3,573,440
1.3
Miller, Walter Management Board Member
Transaction date
Purchase
Price
2.49
Quantity 2,002
Value €4,986
1.3
Miller, Walter Management Board Member
Transaction date
Purchase
Price
3.02
Quantity 2,003
Value €6,050
0.9
Baur, Dr. Georg F. Supervisory Board Member
Transaction date
Purchase
Price
3.09
Quantity 20,012
Value €61,837
2.7
Pahl, Prof. Dr. Andreas Management Board Member
Transaction date
Purchase
Price
3.38
Quantity 2,997
Value €10,130
2.7
Pahl, Prof. Dr. Andreas Management Board Member
Transaction date
Purchase
Price
4.00
Quantity 2,500
Value €10,000
2.7
Pahl, Prof. Dr. Andreas Management Board Member
Transaction date
Purchase
Price
2.15
Quantity 5,000
Value €10,750
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-10 2026-03-09 S Sale
3.1
Kudlek, Dr. Birgit
Supervisory Board Member
98,761
442.19
€1,405,398 		98,761 442.19 €1,405,398
2026-03-10 2026-03-09 S Sale
3.1
Kudlek, Dr. Birgit
Supervisory Board Member
67,393
458.77
€593,776 		67,393 458.77 €593,776
2024-08-29 2024-08-28 B Purchase
1.3
Miller, Walter
Management Board Member
91,357
405.04
€3,573,440 		91,357 405.04 €3,573,440
2024-08-29 2024-08-28 B Purchase
1.3
Miller, Walter
Management Board Member
2,002
2.49
€4,986 		2,002 2.49 €4,986
2024-04-17 2024-04-15 B Purchase
1.3
Miller, Walter
Management Board Member
2,003
3.02
€6,050 		2,003 3.02 €6,050
2024-03-26 2024-03-25 B Purchase
0.9
Baur, Dr. Georg F.
Supervisory Board Member
20,012
3.09
€61,837 		20,012 3.09 €61,837
2023-12-18 2023-12-15 B Purchase
2.7
Pahl, Prof. Dr. Andreas
Management Board Member
2,997
3.38
€10,130 		2,997 3.38 €10,130
2023-05-26 2023-05-25 B Purchase
2.7
Pahl, Prof. Dr. Andreas
Management Board Member
2,500
4.00
€10,000 		2,500 4.00 €10,000
2019-12-06 2019-12-04 B Purchase
2.7
Pahl, Prof. Dr. Andreas
Management Board Member
5,000
2.15
€10,750 		5,000 2.15 €10,750
Explore more

More insider trading research around Heidelberg Pharma AG

More insider trades in Germany
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe